Leucadia National - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 70 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Leucadia National ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,877,570
-8.6%
330,758
-7.0%
0.05%
-8.6%
Q2 2023$6,428,547
+14.7%
355,758
-20.2%
0.06%
+28.9%
Q1 2023$5,603,178
-14.3%
445,7580.0%0.04%0.0%
Q4 2022$6,534,812445,7580.04%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,084,370$30,432,0004.62%
Vivo Capital, LLC 2,312,368$33,761,0003.39%
Frazier Life Sciences Management, L.P. 1,787,527$26,098,0002.46%
Cormorant Asset Management, LP 1,875,000$27,375,0002.07%
Sands Capital Ventures, LLC 260,000$3,796,0001.04%
Ghost Tree Capital, LLC 120,000$1,752,0000.91%
RTW INVESTMENTS, LP 2,013,601$29,399,0000.76%
COWEN AND COMPANY, LLC 534,524$7,804,0000.75%
Perceptive Advisors 1,296,416$18,927,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,324,214$19,334,0000.40%
View complete list of TARSUS PHARMACEUTICALS INC shareholders